System-Level Intervention for Visual Impairment
(EYES-UM Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
Individuals living in Upper Manhattan have limited access to eye care, high vision impairment rates, and poor ocular health outcomes. To improve eye care and vision health outcomes, the Eye Health Intervention Study in Upper Manhattan (EYES-UM) will conduct eye health screenings in accessible primary care health centers and senior centers and implement a behavioral intervention to improve adherence for those referred for in-office eye care. The proposed innovative, 2:1 cluster-randomized clinical trial, will recruit adults age 40 and older in Upper Manhattan with known rates of inadequate eye care. A total of 10 settings in Upper Manhattan, comprised of primary care offices, senior centers, and organizations, confirms access to 17,000 individuals living at or below the NYC.gov poverty measure. This study will conduct ocular tests (visual acuity, intraocular pressure, fundus images) during screenings. To ensure that all participants receive the basic level of service, all participants who fail the eye health screening will be seen the same day by a study optometrist and eyeglasses will be provided at no charge. Educational workshops and an Advisory Board will support recruitment. Intervention Arm participants will receive ongoing support with scheduling eye exams and transportation by trained Study Coordinators. All participants will be followed prospectively for 2 years. The study is guided by the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) Framework. Conducting Focus Groups with health policy stakeholders ensures iterative input during the study to bridge and translate EYES-UM findings into a Vision Health Policy Roadmap for scalable implementation of vision care delivery models, focusing on adherence.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on eye health screenings and support, so it's unlikely that you would need to change your medications.
How does the System-Level Intervention treatment for visual impairment differ from other treatments?
The System-Level Intervention for visual impairment is unique because it focuses on a comprehensive approach that may include various components like rehabilitation programs, training in low vision devices, and possibly other supportive measures, rather than just addressing the visual impairment itself. This holistic approach aims to improve overall functioning, participation, and quality of life, especially in children, which is not typically the focus of standard treatments.12345
What data supports the effectiveness of the treatment System-Level Intervention for Visual Impairment?
Who Is on the Research Team?
Lisa A. Hark, PhD, MBA
Principal Investigator
Columbia University Department of Ophthalmology
Are You a Good Fit for This Trial?
This trial is for adults aged 40+ living in Upper Manhattan, who visit community health settings at least once a year and live independently. It aims to help those with eye conditions like glaucoma, cataracts, or diabetic retinopathy by providing screenings and follow-up care.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants in the Intervention Arm receive assistance with scheduling eye exams and transportation over 2 years
Usual Care
Participants receive basic eye health screening, optometric exam if needed, and eyeglasses at no charge
Follow-up
Participants are monitored for adherence to recommended in-office eye exams and detection of eye disease
What Are the Treatments Tested in This Trial?
Interventions
- System-Level Intervention
- Usual Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
National Eye Institute (NEI)
Collaborator